August 2026
The direct-to-consumer genetic testing market reached USD 2.45 billion in 2026, featuring leading direct-to-consumer genetic testing companies such as Identigene, Karmagenes, Living DNA, Mapmygenome.
September 2026
The global genetic testing market size is calculated at USD 27.32 billion in 2026 and is projected to hit around USD 71.09 billion by 2035 with a soild CAGR of 11.26%.
September 2026
The direct-to-consumer laboratory testing market size is projected to hit around USD 8.69 billion by 2035 from USD 4.08 billion in 2026 with a CAGR of 8.77%.
September 2026
The global genetic toxicology testing market size was evaluated at USD 2.49 billion in 2026 and is predicted to hit around USD 5.97 billion by 2035, growing at a CAGR of 10.20%.
September 2026
The US direct-to-consumer laboratory testing market size was evaluated at USD 1.34 billion in 2026 and is predicted to hit around USD 2.92 billion by 2035, growing at a CAGR of 9.03%.
June 2026
The global prenatal and newborn genetic testing market size is projected to hit around USD 30.94 billion by 2035, increasing from USD 10.48 billion in 2026, with at a solid CAGR of 12.8%.
February 2026
The global cardiovascular genetic testing market size was evaluated at USD 11.34 billion in 2025 and is predicted to hit around USD 33.38 billion by 2035, growing at a CAGR of 11.4%.
June 2025
The consumer genomics market size was valued at USD 2.03 billion in 2024 and it is expected hit around USD 18.83 billion by 2034 with a CAGR of 24.95%.
September 2026
The global blood testing market size was estimated at USD 121.51 billion in 2026 and is projected to hit around USD 224.14 billion by 2035 with a notable CAGR of 7.06%.
September 2026
The U.S. point of care infectious disease testing market size is projected to hit around USD 5.27 billion by 2035, growing at a CAGR of 8.98% from 2026 to 2035.
September 2026
The global epigenetics drugs and diagnostic technologies market size is estimated to hit around USD 79.03 billion by 2035 increasing from USD 23.13 billion in 2026, with a CAGR of 14.63%.
September 2026
The global precision genomic testing market size is valued at USD 20.55 billion in 2026 and is expected to hit around USD 69.72 billion by 2035, growing at a CAGR of 14.57%.
September 2026
The molecular cytogenetics market size reached USD 3.20 billion in 2026, with leading molecular cytogenetics market companies including Thermo Fisher Scientific, Illumina, Danaher, Roche Diagnostics.
September 2026
The personalized testing and supplements market size reached USD 5.61 billion in 2026, with leading personalized testing and supplements market companies including Viome Life Sciences, DSM Nutritional Products AG.
September 2026
The global adiponectin testing market size was evaluated at USD 60.56 billion in 2026 and is predicted to hit around USD 120.35 billion by 2035, growing at a CAGR of 7.93%.
September 2026
The global animal testing and ecotoxicology testing market was valued at USD 4,925.33 million in 2025. Research by Deepa Pandey, Senior Research Analyst.
September 2026
The global extractable and leachable (E&L) testing services market was valued at USD 1,113.69 million in 2025 and is expected to expand at a CAGR of 12.74% during the forecast period. Research by Deepa Pandey, Senior Research Analyst.
September 2026
The preclinical bioanalytical testing services market was valued at USD 1.18 billion in 2025 and is expected to expand at a CAGR of 10.80% from 2026 to 2035. Research by Deepa Pandey, Senior Research Analyst.
September 2026
The global endotoxin testing market size is expected to increase from USD 1.60 billion in 2026 to hit around USD 3.78 billion by 2035, growing at a CAGR of 10.05%.
September 2026
The global diagnostic testing market size reached USD 213.03 billion in 2026 and is projected to hit around USD 281.56 billion by 2035, growing at a CAGR of 3.08%.
September 2026
The global esoteric testing market size is estimated at USD 41.05 billion in 2026 and is predicted to hit around USD 100.94 billion by 2035 with a CAGR of 10.53%.
September 2026
The global endocrine testing market size was estimated at USD 16.97 billion in 2026 and is expected to surge around USD 35.43 billion by 2035 with a CAGR of 8.53%
September 2026
The non-invasive prenatal testing market size was USD 8.05 billion in 2026, with leading non-invasive prenatal testing market players including Genesis Genetics, Natera, Centogene, Eurofins LifeCodexx GmbH.
September 2026
The global toxicology testing services market size is estimated to surpass around USD 70.78 billion by 2035 from USD 43.55 billion in 2026, with a CAGR of 5.55%.
September 2026
The non-destructive testing (NDT) market size accounted for USD 24.59 billion in 2025 and is expected to hit around USD 56.23 billion by 2035 with a CAGR of 9.69%.
September 2026
The global noise vibration and harshness testing market size is estimated to hit around USD 4.62 billion by 2034 increasing from USD 2.84 billion in 2026, at a CAGR of 6.30%.
September 2026
The global bacteriological testing market size was evaluated at USD 28.02 billion in 2026 and is predicted to hit around USD 54.35 billion by 2035, growing at a CAGR of 7.64%.
September 2026
The global microbiology testing market size reached USD 6.88 billion in 2026 and is projected to be worth around USD 14.74 billion by 2035 with a CAGR of 8.85%.
September 2026
The global generative AI in testing market size was evaluated at USD 73.19 million in 2026 and is predicted to hit around USD 439.81 million by 2035, growing at a CAGR of 22.05%.
September 2026
The rapid microbiology testing market size was USD 4.07 billion in 2026, with leading rapid microbiology testing market players including Accelerate Diagnostics, Inc., Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Inc.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com